Yeast β-glucan modulates macrophages and improves antitumor NK-cell responses in cancer
Clinical and Experimental Immunology · 11.12.2023 · 214 (1) · 50-60
DOI: 10.1093/cei/uxad080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 17.07.2023. Verfasst von Zhichao Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Oncology, Medical Research Center, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China. Hauptthemen laut MEDLINE: beta-Glucans, Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Health Commission, Changzhou Sci & Tech Program.
Abstract (Originalsprache)
As the largest proportion of myeloid immune cells in tumors, macrophages play an important role in tumor growth and regression according to their different phenotypes, thus reprogramming macrophages has become a new research direction for cancer immunotherapy. Yeast-derived whole β-glucan particles (WGPs) can induce M0 macrophages to differentiate into M1 macrophages and convert M2 macrophages and tumor-associated macrophages (TAMs) into M1 macrophages. In vitro, studies have confirmed that WGP-treated macrophages increase the activating receptors in natural killer cells (NK cells) and enhance the cytotoxicity of NK cells. The extracellular regulated protein kinases (ERK) signaling pathway is involved in WGP-mediated regulation of the macrophage phenotype. Further in vivo studies show that oral WGP can significantly delay tumor growth, which is related to the increased proportion of macrophages and NK cells, the macrophage phenotype reversal, and the enhancement of NK cell immune function. NK-cell depletion reduces the therapeutic efficacy of WGP in tumor-bearing mice. These findings revealed that in addition to T cells, NK cells also participate in the antitumor process of WGP. It was confirmed that WGP regulates the macrophage phenotype to regulate NK-cell function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Oncology, Medical Research Center, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China.
ORCID-Profile: Chunjian Qi
Förderung
- National Natural Science Foundation of China
- Jiangsu Provincial Health Commission
- Changzhou Sci & Tech Program
Zitieren
APA
Zhu, Z., He, L., Bai, Y., Xia, L., Sun, X., & Qi, C. (2023). Yeast β-glucan modulates macrophages and improves antitumor NK-cell responses in cancer. Clinical and Experimental Immunology, 214(1), 50-60. https://doi.org/10.1093/cei/uxad080
Vancouver
Zhu Z, He L, Bai Y, Xia L, Sun X, Qi C. Yeast β-glucan modulates macrophages and improves antitumor NK-cell responses in cancer. Clinical and Experimental Immunology. 2023;214(1):50-60. doi:10.1093/cei/uxad080
BibTeX
@article{Zhu2023,
author = {Zhu, Zhichao and He, Liuyang and Bai, Yu and Xia, Lei and Sun, Xiao and Qi, Chunjian},
title = {Yeast β-glucan modulates macrophages and improves antitumor NK-cell responses in cancer},
journal = {Clinical and Experimental Immunology},
year = {2023},
volume = {214},
number = {1},
pages = {50--60},
doi = {10.1093/cei/uxad080}
}
EUVIMED